Genprex, Inc. (GNPX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:00AM EDT. Market open.
| Previous close | 2.4200 |
| Open | 2.3899 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.3647 - 2.4693 |
| 52-week range | 2.0900 - 42.4000 |
| Volume | |
| Avg. volume | 51,968 |
| Market cap | 5.182M |
| Beta (5Y monthly) | -0.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
Genprex (GNPX) gains 9.5% after expanding clinical study sites in the United States for the early to mid-stage study of lead candidate, Reqorsa, to treat lung cancer patients.
- Zacks
GENPREX (GNPX) Upgraded to Buy: Here's What You Should Know
GENPREX (GNPX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Investing.com
5 big analyst cuts: BofA sees 'increased risks' for Dick's Sporting Goods
BofA analysts slashed retail chain Dick's Sporting Goods (NYSE:DKS) to Neutral from Buy on Thursday with a price target of $125, down from the prior $180.
© 2024 Yahoo. All rights reserved.